MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinsonism"

  • 2016 International Congress

    Serum level of vitamin D3 in patients with neurodegenerative diseases compared to healthy adults and its correlation with the years spent from the initial diagnosis

    A.N. Taravari (Skopje, Macedonia)

    Objective: Vitamin D is an important factor responsible for many physiologic functions. Vitamin D deficiency is associated with increased risk of neurodegenerative disease. Background: The…
  • 2016 International Congress

    Association of Parkinson’s disease with essential tremor

    D. Aygun (Samsun, Turkey)

    Objective: In this study we present the clinical characteristics of 10 patients (6 males, 4 females) with both essential tremor (ET) and Parkinson's disease (PD).…
  • 2016 International Congress

    ADS-5102 (amantadine HCl) extended-release capsules reduced levodopa-induced dyskinesia in the phase 3 EASE LID study

    R. Pahwa, C.M. Tanner, R.A. Hauser, P. Nausieda, D.D. Truong, K. Hull, P. Agarwal, R. Johnson, A.E. Ruby, N.L. McClure, M.J. Stempien (Kansas City, KS, USA)

    Objective: To investigate the efficacy and safety of ADS-5102 (amantadine HCl) extended release capsules 340 mg daily at bedtime for the treatment of levodopa-induced dyskinesia…
  • 2016 International Congress

    The impact of STN DBS on kinetic tremor in Parkinson’s disease patients

    S. Szlufik, M. Szumilas, J. Dutkiewicz, D. Koziorowski, T. Mandat, E. Slubowska (Warsaw, Poland)

    Objective: The aim of the study is to evaluate the impact of STN DBS on kinetic tremor in PD patients in comparison to pharmacologically treated…
  • 2016 International Congress

    Classification and recommendation of nonpharmacological therapies for Parkinson’s disease

    T.T.C. Capato, C.H. Fen, E.R. Barbosa (São Paulo, Brazil)

    Objective: A multidisciplinary specialized treatment including physiotherapy, speech and language therapy, occupational therapy (OT) associated to the ideal pharmacological treatment and surgical is recommended to…
  • 2016 International Congress

    The study of clinical outcome of deep brain stimulation for the idiopathic Parkinson’s disease at 6 months follow-up

    P. Papitak, M. Aphiwatthanakun, T. Srikijvilaikul, N. Limotai (Bangkok, Thailand)

    Objective: The aim of this study was to assess the motor and psychiatric outcomes at 6 months after subthalamic nucleus deep brain stimulation (STN-DBS) in…
  • 2016 International Congress

    Longitudinal changes of speech and voice disorders following subthalamic stimulation in Parkinson’s disease patients

    T. Tsuboi, H. Watanabe, Y. Tanaka, R. Ohdake, K. Kawabata, K. Hara, M. Ito, M. Hirayama, Y. Fujimoto, Y. Kajita, M. Katsuno, G. Sobue (Nagoya, Japan)

    Objective: To elucidate longitudinal changes of speech and voice disorders in Parkinson's disease (PD) patients treated with subthalamic nucleus deep brain stimulation (STN-DBS). Background: Previously,…
  • 2016 International Congress

    Deep brain stimulation in a Parkinsonian patient with sever psychiatric complication

    T. Ichikawa, Y. Hashimoto, T. Obuchi, K. Kobayashi, H. Oshima (Ageo, Japan)

    Objective: In order to know what degree of psychiatric complication is hazard to deep brain stimulation (DBS) in patients with Parkinson's disease, we report and…
  • 2016 International Congress

    Transcranial unilateral MR guided high intensity focused ultrasound in Parkinson’s disease or essential tremor seems to be save concerning dysphagia and dysarthria

    S. Hägele-Link, N.A. Wegener, S.R. Schreglmann, J. Rosenfeld, M. Mueller-Baumberger, R. Bauer, A. Lebeda, B. Werner, E. Martin, G. Kägi (St. Gallen, Switzerland)

    Objective: To report first results of a study monitoring speech and swallowing function after lesional functional neurosurgery for movement disorders. Background: Transcranial MR-guided high intensity…
  • 2016 International Congress

    Imaging-based differential diagnosis between multiple system atrophy and Parkinson’s disease

    W. Sako, T. Abe, N. Murakami, Y. Miyazaki, Y. Izumi, M. Harada, R. Kaji (Tokushima, Japan)

    Objective: We aimed to directly compare middle cerebellar peduncle (MCP) width, apparent diffusion coefficient (ADC) value of the putamen and cerebellum, and 123I-metaiodobenzylguanidine (MIBG) myocardial…
  • « Previous Page
  • 1
  • …
  • 362
  • 363
  • 364
  • 365
  • 366
  • …
  • 388
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
    • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
    • Covid vaccine induced parkinsonism and cognitive dysfunction
    • Life expectancy with and without Parkinson’s disease in the general population
    • Effect of Ketone Ester Supplementation on Motor and Non-Motor symptoms in Parkinson's Disease
    • An atypical and interesting feature of Parkinson´s disease
    • Effect of marijuana on Essential Tremor: A case report
    • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
    • Covid vaccine induced parkinsonism and cognitive dysfunction
    • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
    • Patients with Essential Tremor Live Longer than their Relatives
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley